Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVR-Reference-Cited by-同舟云学术

Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVR

Published:2021-12-02 Issue:23 Volume:385 Page:2150-2160
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Van Mieghem Nicolas M.¹,Unverdorben Martin¹,Hengstenberg Christian¹,Möllmann Helge¹,Mehran Roxana¹,López-Otero Diego¹,Nombela-Franco Luis¹,Moreno Raul¹,Nordbeck Peter¹,Thiele Holger¹,Lang Irene¹,Zamorano José L.¹,Shawl Fayaz¹,Yamamoto Masanori¹,Watanabe Yusuke¹,Hayashida Kentaro¹,Hambrecht Rainer¹,Meincke Felix¹,Vranckx Pascal¹,Jin James¹,Boersma Eric¹,Rodés-Cabau Josep¹,Ohlmann Patrick¹,Capranzano Piera¹,Kim Hyo-Soo¹,Pilgrim Thomas¹,Anderson Richard¹,Baber Usman¹,Duggal Anil¹,Laeis Petra¹,Lanz Hans¹,Chen Cathy¹,Valgimigli Marco¹^ORCID,Veltkamp Roland¹,Saito Shigeru¹,Dangas George D.¹

Affiliation:

1. From the Department of Cardiology, Erasmus University Medical Center, Thoraxcenter, Rotterdam, the Netherlands (N.M.V.M., E.B.); Daiichi Sankyo, Basking Ridge, NJ (M.U., J.J., A.D., C.C.); the Department of Internal Medicine II, Division of Cardiology, Vienna General Hospital, Medical University, Vienna (C.H., I.L.); the Department of Internal Medicine, St. Johannes Hospital, Dortmund (H.M.), the Department of Internal Medicine I, University Hospital Würzburg, Würzburg (P.N.), the Department of Internal...

Funder

Daiichi Sankyo, Inc.

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa2111016

Cited by 173 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Residual Stroke Risk in Patients With Atrial Fibrillation following Transcatheter Aortic Valve Implantation: What Else Can We Do to Mitigate Risk?;The American Journal of Cardiology;2024-10

2. The impact of stroke and bleeding on mortality and quality of life during the first year after TAVI: A POPular TAVI subanalysis;Catheterization and Cardiovascular Interventions;2024-09-11

3. Hematological Complications From Transcatheter Aortic Valve Replacement (TAVR): Recognition and Treatment;Cardiology in Review;2024-09-10

4. Risk Factors of Ischemic Stroke in Patients With Atrial Fibrillation After Transcatheter Aortic Valve Implantation from the Randomized ENVISAGE-TAVI AF Trial;The American Journal of Cardiology;2024-09

5. Dose Reduction of Edoxaban in Patients 80 Years and Older With Atrial Fibrillation;JAMA Cardiology;2024-09-01